Table 3.
Antitumor effects of ivermectin in vitro
Tumor type | Cell lines | [µM] | Effects | Reference |
---|---|---|---|---|
Human leukemia | OCI-AML2 | 5, | Induces cell death through upregulation of ROS. | [44] |
HL60 | 10, | |||
U937 | 15, | |||
K61a | 20 | |||
Prostate cancer | DU145 | |||
PPC-1 | ||||
Human glioblastoma | U87 | 1, | Induces growth inhibition, apoptosis and anti-angiogenesis. | [47] |
T98G | 5, | |||
10 | ||||
Ovarian cancer | TYK-nu | 0.1, | Inhibition of cell proliferation. | [9] |
KOC7C | 1, | |||
SKOV3 | 10, | |||
RMUG-S | 100 | |||
HEI-193 | ||||
Breast cancer | MDA-MB-435, | 5, | Stimulates autophagy and inhibition of cell proliferation. | [54] |
MDA-MB-231 | 10, | |||
MDA-MB-468 | 15, | |||
MDA-MB-361 | 20 | |||
MCF-7 | ||||
HS578T | ||||
Murine breast cancer | 4T1.2 | 1, | Induces apoptosis and necrosis. Induces autophagy. | [50] |
DDHer2 | 4, | |||
8, | ||||
Murine melanoma | C57BL/6 | 16 | Inhibition of cell proliferation and clonogenic capacity. | |
Murine colon adenocarcinoma | CT.26 | Increases the amount of ROS. | ||
Human breast cancer | MDA-MB-231 | |||
MCF7 | ||||
SKBR3 | ||||
Human melanoma | A2058 | |||
A375 | ||||
Human pancreatic cancer | PANC1 | |||
MiaPaca2 | ||||
Human prostate cancer | DU145 | |||
Human head and neck cancer | A253 | |||
Human leukemia | MV411 | |||
Human colon cancer | CC14 | 0.1, | Inhibits cell proliferation and induces apoptosis. | [57] |
CC36 | 1, | |||
Ls174T | 5, | |||
HT29 | 10 | |||
Human glioblastoma | DLD1 | |||
U251 | ||||
Human melanoma | SKMe12 | |||
Murine breast cancer | 4T1 | 0.01, | Inhibition of invasiveness and restoration of tamoxifen sensitivity. | [59] |
MMTV-Myc | 0.1, | |||
Human breast cancer | MDA-MB-231 | 1 | Inhibition of cell growth and metastases. | |
D3H2LN | ||||
Human breast cancer | MDA-MB-231 | 0.2, | Preferentially inhibits cell viability and clonogenicity of the stem cell population. | [67] |
0.4, | ||||
0.8, | ||||
1, | ||||
5, | ||||
8 |